Brown: Neurons From Patient Blood Cells Enable Researchers to Test Treatments for Genetic Brain Disease
February 11, 2021
February 11, 2021
PROVIDENCE, Rhode Island, Feb. 11 (TNSJou) -- Brown University issued the following news:
New research provides insights into the treatment of Christianson syndrome (CS), an X-linked genetic disease characterized by reduced brain growth after birth, intellectual disability, epilepsy and difficulties with balance and speech.
"One of the major challenges in developing treatments for human brain disorders, like CS, is developing an experimental system for testing pot . . .
New research provides insights into the treatment of Christianson syndrome (CS), an X-linked genetic disease characterized by reduced brain growth after birth, intellectual disability, epilepsy and difficulties with balance and speech.
"One of the major challenges in developing treatments for human brain disorders, like CS, is developing an experimental system for testing pot . . .